US Patent Issued to International AIDS Vaccine Initiative, Oregon Health and Science University on Oct. 14 for "Recombinant cytomegalovirus vectors as vaccines for tuberculosis" (New York, Oregon Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,018, issued on Oct. 14, was assigned to International AIDS Vaccine Initiative Inc. (New York) and Oregon Health and Science University (Portland, Ore.).

"Recombinant cytomegalovirus vectors as vaccines for tuberculosis" was invented by Thomas G. Evans (New York), Ravi Anantha (New York), Aurelio M. Bonavia (New York), Dominick J. Laddy (New York), Louis Picker (Beaverton, Ore.), Scott Hansen (Beaverton, Ore.) and Guangwu Xu (Beaverton, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomeg...